<?xml version="1.0" encoding="UTF-8"?>
<p>Changes in physical, metabolic and psychological processes that occur during children’s growth, from birth to adulthood, suggest that children should not be considered as young adults, and nor should they be grouped as a single group. Rather, the pharmaceutical development of paediatric drugs should focus on several acceptable dosage forms that are able to meet the needs of most children in different age groups. This can be achieved by developing dosage forms which facilitate the administration of a dose range which would vary according to the child’s age and/or other important parameters [
 <xref rid="B4-pharmaceutics-13-00387" ref-type="bibr">4</xref>]. 
</p>
